Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,183,244
+$722,782 QoQ
Shares Held
12,650
+11.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#1,616
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OAKWORTH CAPITAL, INC. holds $21,742,030 across 13 Drug Manufacturers - General names. ABBV ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,682 | $5,615,730 | |
| 2 | MRK |
Merck & Co., Inc.
|
37,177 | $4,777,244 | |
| 3 | JNJ |
Johnson & Johnson
|
18,417 | $4,677,363 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
12,650 | $3,183,244 | |
| 5 | AZN |
Astrazeneca PLC
|
4,201 | $796,593 | |
| 6 | AMGN |
Amgen Inc
|
2,008 | $727,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,513 | $605,758 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,689 | $592,407 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,183,244 | 12,650 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,460,462 | 11,313 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,432,502 | 10,646 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,241,537 | 9,681 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,702,876 | 9,174 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,128,513 | 10,159 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,934,085 | 10,884 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,169,119 | 10,984 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,359,428 | 13,756 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,538,291 | 13,939 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $2,049,012 | 13,222 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,957,455 | 13,132 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,777,627 | 13,194 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,097,468 | 13,161 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,021,740 | 12,510 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,746,071 | 13,010 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,994,142 | 13,020 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,117,966 | 13,065 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,668,668 | 12,324 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,267,903 | 11,754 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,291,304 | 11,464 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $1,214,877 | 11,226 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,072,357 | 10,008 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $857,681 | 9,792 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $966,483 | 9,844 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $750,699 | 9,853 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||